Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Fatigue × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 23 Endometrial Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms, Male 2 Breast Carcinoma In Situ 2 Sleep Wake Disorders 1 Paget's Disease, Mammary 1 Gliosarcoma 1 Glioblastoma 1 Fatigue 1 Desmoid Tumors 1 Central Nervous System Neoplasms 1

Interventions

Therapeutics 4 Counseling 2 exemestane 1 Triptorelin Pamoate 1 Taxes 1 Tamoxifen 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Polymerase Chain Reaction 1 Paclitaxel 1 Microarray Analysis 1 Metformin 1 Mental Status and Dementia Tests 1 Interviews as Topic 1 Gonadotropin-Releasing Hormone 1 Gene Expression Profiling 1 Exercise Test 1 Epoetin Alfa 1 Enzyme-Linked Immunosorbent Assay 1 Early Intervention, Educational 1 Dexamethasone 1 Carboplatin 1 Brachytherapy 1 Analgesia 1 Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00659373 2016-07-25

Co-SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed

86 enrolled 4 charts

Breast Neoplasms, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡